Richard D. Gelber

dana-farber cancer institute and harvard medical school and harvard t.h. chan school of public health and frontier science & technology research foundation

H指数:133

被引数:9.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Decluttering Chemotherapy Agents for HER2+ Early Breast Cancer: Do We Still Need Carboplatin?

为HER2阳性早期乳腺癌简化化疗方案：我们是否仍需要卡铂？

European Journal of Cancer

IF7.1

2026-09-030

PRE

“Neoadjuvant Trastuzumab Deruxtecan for High-Risk HER2-Positive Early Breast Cancer: Does the Evidence Support Its Use as a New Standard-of-Care?”

新辅助治疗中曲妥珠单抗德鲁替康用于高危HER2阳性早期乳腺癌：现有证据是否支持其作为新的标准治疗方案？

European Journal of Cancer

IF7.1

2026-05-140

PRE

Prognostic value of patient-reported depression in women with hormone-responsive early breast cancer in TEXT and SOFT

TEXT和SOFT研究中激素受体阳性早期乳腺癌女性患者报告抑郁的预后价值

Cancer

IF5.1

2025-09-230

PRE

Karin Ribi PhD; Bernard F. Cole PhD; Gini F. Fleming MD; Barbara A. Walley MD; Prudence A. Francis MD; Ehtesham Abdi MD; Harold J. Burstein MD, PhD; Kit L. Cheng MD; Stephen K. L. Chia MD, FRCP; Shaker R. Dakhil MD; Nancy E. Davidson MD; Stephen A. Della-Fiorentina MD; Ashley E. Frith MD; Ellis Levine MD; Sasha Lupichuk MD; Kathleen Pritchard MD; Muhammad Salim MD; Vered Stearns MD; Josephine Stewart MD; Vicente Valero MD; Andre van der Westhuizen MD; Olivia Pagani MD; Sherene Loi MD, PhD; Marco Colleoni MD; Richard D. Gelber PhD; Aron Goldhirsch MD; Alan S. Coates MD; Meredith M. Regan ScD; Jürg Bernhard PhD

Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial

POSITIVE试验中，预测乳腺癌患者为尝试生育而中断辅助内分泌治疗时生育力的激素因素

breast

IF0

2025-07-260

OAAI

Isabelle Demeestere; Samuel M. Niman; Ann H. Partridge; Daniela S. Diego; Roswitha Kammler; Monica Ruggeri; Marco Colleoni; Chikako Shimizu; Cristina Saura; Karen A. Gelmon; Anna B. Saetersdal; Judith R. Kroep; Audrey Mailliez; Frederic Amant; Manuel Ruız-Borrego; Jeong Eon Lee; Akemi Kataoka; Janice M. Walshe; Junko Takei; Simona Borstnar; Virginia F. Borges; Christobel Saunders; Snezana Susnjar; Vesna Bjelic-Radisic; Fatima Cardoso; Jane Lowe Meisel; Jennifer F. Kawwass; Tanja Spanic; Sarra El-Abed; Martine Piccart; Larissa A. Korde; Aron Goldhirsch; Richard D. Gelber; Olivia Pagani; Hatem A. Azim; Fedro A. Peccatori

Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: an international cohort study

风险降低手术与年轻BRCA携带者乳腺癌患者生存期的关联：一项国际队列研究

lancet oncology

IF0

2025-05-080

PRE

Eva Blondeaux; Amir Sonnenblick; Elisa Agostinetto; Raphaëlle Bas; Hee J Kim; Maria A Franzoi; Rinat Bernstein-Molho; Sabine Linn; Ava Kwong; Katarzyna Pogoda; Judith Balmana; Ann Smeets; Jyoti Bajpai; Halle C F Moore; Ann H Partridge; Kelly-Anne Phillips; Angela Toss; Christine Rousset-Jablonski; Fedro A Peccatori; Tiphaine Renaud; Alberta Ferrari; Shani Paluch-Shimon; Pablo Mando; Jeong E Lee; Robert Fruscio; Wanda Cui; Stephanie M Wong; Claudio Vernieri; Kathryn J Ruddy; Maria V Dieci; Alexios Matikas; Mariya Rozenblit; Deniz C Guven; Minna Lee; Cynthia Villarreal-Garza; Shelley E Hwang; Laura De Marchis; Fabio Puglisi; Zoe Kemp; Pedro A Meireles; Anastasia Parokonnaya; Gustavo Werutsky; Maiko Okano; Hatem A Azim; Kleida Mati; Shoshana Rosenberg; Richard Gelber; Luca Boni; Matteo Lambertini

Association of statin use on survival outcomes of patients with early-stage HER2-positive breast cancer in the APHINITY trial

在APHINITY试验中，他汀类药物使用与早期HER2阳性乳腺癌患者生存结局的关联

BREAST CANCER RESEARCH AND TREATMENT

IF3

2025-04-280

Outcomes of patients with advanced solid tumors who discontinued immune-checkpoint inhibitors: a systematic review and meta-analysis

停用免疫检查点抑制剂的晚期实体瘤患者的结局: 系统回顾和荟萃分析

ECLINICALMEDICINE

IF10

2024-07-010

OAAI

Fertility preservation and assisted reproductive technologies (ART) in breast cancer (BC) patients (pts) interrupting endocrine therapy (ET) to attempt pregnancy

CANCER RESEARCH

IF16.6

2024-05-020

PRE

Azim, Hatem; Niman, Samuel; Partridge, Ann; Demeestere, Isabelle; Ruggeri, Monica; Colleoni, Marco; Saura, Cristina; Shimizu, Chikako; Saetersdal, Anna; Kroep, Judith; Mailliez, Audrey; Warner, Ellen; Borges, Virginia; Amant, Frederic; Gombos, Andrea; Kataoka, Akemi; Rousset-Jablonski, Christine; Borstnar, Simona; Takei, Junko; Lee, Jeong Eon; Walshe, Janice; Ruiz-Borrego, Manuel; Moore, Halle; Saunders, Christobel; Bjelic-Radisic, Vesna; Susnjar, Snezana; Cardoso, Fatima; Klar, Natalie; Spanic, Tanya; Ruddy, Kathryn; Piccart, Martine; Korde, Larissa; Goldhirsch, Aron; Gelber, Richard; Pagani, Olivia; Peccatori, Fedro Alessandro

Adding atezolizumab to adjuvant chemotherapy for stage II and III triple-negative breast cancer is unlikely to improve efficacy: interim analysis of the ALEXANDRA/IMpassion030 phase 3 trial

CANCER RESEARCH

IF16.6

2024-05-023

PRE

Ignatiadis, Michail; Bailey, Andrew; McArthur, Heather; El-Abed, Sarra; de Azambuja, Evandro; Metzger, Otto; Chui, Steve; Dieterich, Max; Perretti, Thomas; Steger, Guenther; Jassem, Jacek; Lee, Soo Chin; Higgins, Michaela; Zarba, Jose; Schmidt, Marcus; Gomez, Henry; Guerrero-Zotano, Angel; Moscetti, Luca; Chiu, Joanne Win Yang; DuFrane, Carter; Honvault, Vanessa; Altarcheh, Rosa; Molinero, Luciana; Ellingson, Andrew; Munzone, Elisabetta; Ben-Baruch, Noa Efrat; Bajetta, Emilio; Ohno, Shinji; Im, Seock-Ah; Werutsky, Gustavo; Gal-Yam, Einav; Gonzalez-Farre, Xavier; Tseng, Ling-Ming; Jacot, William; Gluz, Oleg; Shao, Zhimin; Shparyk, Yaroslav; Sinielnikov, Ivan; Anastasia, Zimina; Vasiliev, Aleksandr; Shearer-Kang, Esther; Winer, Eric; Martins-Branco, Diogo; Fielding, Shona; Cameron, David; Viale, Giuseppe; Saji, Shigehira; Gelber, Richard; Piccart, Martine

Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium (vol 203, pg 351, 2023)

原发转移性乳腺癌患者的原发肿瘤手术: 比利时一项基于全国人口的回顾性队列研究 (203卷，351页，2023页)

BREAST CANCER RESEARCH AND TREATMENT

IF3

2024-04-090

Adjuvant chemotherapy with or without atezolizumab for stage II and III triple-negative breast cancer: final analysis of the ALEXANDRA/ IMpassion030 phase 3 trial

EUROPEAN JOURNAL OF CANCER

IF7.1

2024-03-013

PRE

Surrogate endpoints for overall survival in randomized clinical trials testing immune checkpoint inhibitors: a systematic review and meta-analysis

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-01-291

OAAI

Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium

初发转移性乳腺癌患者原发肿瘤的手术治疗：比利时一项全国性的基于人群的回顾性队列研究

BREAST CANCER RESEARCH AND TREATMENT

IF3

2023-10-259

PRE

Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trials

BREAST

IF7.9

2023-06-014

OAAI

Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer

乳腺癌后中断内分泌治疗以尝试怀孕

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2023-05-0489

Partridge, Ann H.; Niman, Samuel M.; Ruggeri, Monica; Peccatori, Fedro A.; Azim, Hatem A., Jr.; Colleoni, Marco; Saura, Cristina; Shimizu, Chikako; Saetersdal, Anna B.; Kroep, Judith R.; Mailliez, Audrey; Warner, Ellen; Borges, Virginia F.; Amant, Frederic; Gombos, Andrea; Kataoka, Akemi; Rousset-Jablonski, Christine; Borstnar, Simona; Takei, Junko; Lee, Jeong E.; Walshe, Janice M.; Ruiz-Borrego, Manuel; Moore, Halle C. F.; Saunders, Christobel; Bjelic-Radisic, Vesna; Susnjar, Snezana; Cardoso, Fatima; Smith, Karen L.; Ferreiro, Teresa; Ribi, Karin; Ruddy, Kathryn; Kammler, Roswitha; El-Abed, Sarra; Viale, Giuseppe; Piccart, Martine; Korde, Larissa A.; Goldhirsch, Aron; Gelber, Richard D.; Pagani, Olivia

Pregnancy Outcome and Safety of Interrupting Therapy for women with endocrine responsIVE breast cancer: Primary Results from the POSITIVE Trial (IBCSG 48-14/BIG 8-13)

CANCER RESEARCH

IF16.6

2023-03-014

PRE

Partridge, Ann; Pagani, Olivia; Niman, Samuel M.; Ruggeri, Monica; Peccatori, Fedro Alessandro A.; Azim, Hatem A.; Colleoni, Marco; Saura, Cristina; Shimizu, Chikako; Saetersdal, Anna; Kroep, Judith; Mailliez, Audrey; Warner, Ellen; Borges, Virginia F.; Amant, Frederic; Gombos, Andrea; Kataoka, Akemi; Rousset-Jablonski, Christine; Borstnar, Simona; Takei, Junko; Lee, Jeong Eon; Walshe, Janice; Borrego, Manuel Ruiz; Moore, Halle; Saunders, Christobel; Bjelic-Radisic, Vesna; Susnjar, Snezana; Cardoso, Fatima; Smith, Karen L.; Vilarino, Teresa Ferreiro; Ribi, Karin; Ruddy, Kathryn; El-Abed, Sarra; Piccart, Martine; Korde, Larissa A.; Goldhirsch, Aron; Gelber, Richard D.

Ten-year survival of neoadjuvant dual HER2 blockade in patients with HER2-positive breast cancer

EUROPEAN JOURNAL OF CANCER

IF7.1

2023-03-013

PRE

Overall survival in the OlympiA phase Ill trial of adjuvant olaparib in patients with germime pathogenic variants in BRCA1/2 and high-risk, early breast cancer

OlympiA iii期试验中辅助olaparib治疗BRCA1/2中germime致病变异和高危早期乳腺癌患者的总生存率

ANNALS OF ONCOLOGY

IF65.4

2022-12-01198

OAAI

Geyer, C. E., Jr.; Garber, J. E.; Gelber, R. D.; Yothers, G.; Taboada, M.; Ross, L.; Rastogi, P.; Cui, K.; Arahmani, A.; Aktan, G.; Armstrong, A. C.; Arnedos, M.; Balmana, J.; Bergh, J.; Bliss, J.; Delaloge, S.; Domchek, S. M.; Eisen, A.; Elsafy, F.; Fein, L. E.; Fielding, A.; Ford, J. M.; Friedman, S.; Gelmon, K. A.; Gianni, L.; Gnant, M.; Hollingsworth, S. J.; Im, S-A; Jager, A.; Lakhani, S. R.; Janni, W.; Linderholm, B.; Liu, T-W; Loman, N.; Korde, L.; Loibl, S.; Lucas, P. C.; Marme, F.; de Duenas, E. Martinez; McConnell, R.; Phillips, K-A; Piccart, M.; Rossi, G.; Schmutzler, R.; Senkus, E.; Shao, Z.; Sharma, P.; Singer, C. F.; Spanic, T.; Stickeler, E.; Toi, M.; Traina, T. A.; Viale, G.; Zoppoli, G.; Park, Y. H.; Yerushalmi, R.; Yang, H.; Pang, D.; Jung, K. H.; Mailliez, A.; Fan, Z.; Tennevet, I; Zhang, J.; Nagy, T.; Sonke, G. S.; Sun, Q.; Parton, M.; Colleoni, M. A.; Schmidt, M.; Brufsky, A. M.; Razaq, W.; Kaufman, B.; Cameron, D.; Campbell, C.; Tutt, A. N. J.; Johannsson, O. Th

Six-year absolute invasive disease-free survival benefit of adding adjuvant pertuzumab to trastuzumab and chemotherapy for patients with early HER2-positive breast cancer: A Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of the APHINITY (BIG 4-11) trial

EUROPEAN JOURNAL OF CANCER

IF7.1

2022-05-0111

Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial

NPJ BREAST CANCER

IF7.6

2022-02-1612

OAAI

Barroso-Sousa, Romualdo; Tarantino, Paolo; Tayob, Nabihah; Dang, Chau; Yardley, Denise A.; Isakoff, Steven J.; Valero, Vicente; Faggen, Meredith; Mulvey, Therese; Bose, Ron; Hu, Jiani; Weckstein, Douglas; Wolff, Antonio C.; Reeder-Hayes, Katherine; Rugo, Hope S.; Ramaswamy, Bhuvaneswari; Zuckerman, Dan; Hart, Lowell; Gadi, Vijayakrishna K.; Constantine, Michael; Cheng, Kit; Briccetti, Frederick; Schneider, Bryan; Garrett, Audrey Merrill; Marcom, Kelly; Albain, Kathy; DeFusco, Patricia; Tung, Nadine; Ardman, Blair; Nanda, Rita; Jankowitz, Rachel C.; Rimawi, Mothaffar; Abramson, Vandana; Pohlmann, Paula R.; Van Poznak, Catherine; Forero-Torres, Andres; Liu, Minetta; Ruddy, Kathryn J.; Zheng, Yue; Rosenberg, Shoshana M.; Gelber, Richard D.; Trippa, Lorenzo; Barry, William; DeMeo, Michelle; Burstein, Harold; Partridge, Ann; Winer, Eric P.; Krop, Ian; Tolaney, Sara M.

Richard D. Gelber

个人简介

教育背景

工作经历

荣誉奖项

研究方向